Quoin Pharmaceuticals shareholders approved 401(k) matching contribution changes at annual meeting

Quoin Pharmaceuticals held its annual general meeting on Aug. 20, 2026.

Shareholders backed changes to the company’s non-employee director compensation program.

Investors also authorized changes to matching contributions under the company’s 401(k) plan, including for U.S.-based executive officers.